Gyon Technologies Capital Management, LP Savara Inc Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$1.17 - $2.33 $23,024 - $45,852
-19,679 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$1.0 - $1.47 $19,679 - $28,928
19,679 New
19,679 $23,000
Q3 2020

Nov 16, 2020
SELL
$1.09 - $2.21 $15,610 - $31,651
-14,322 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.8 - $3.05 $25,779 - $43,682
14,322 New
14,322 $36,000

Others Institutions Holding SVRA

# of Institutions
129
Shares Held
158M
Call Options Held
67.6K
Put Options Held
29.4K
View Full List

About Savara Inc

SVRA Quotes by TradingView
  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $389M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email